Medicine and Dentistry
Neoplasm
62%
Diffuse Large B-Cell Lymphoma
39%
Non-Hodgkin Lymphoma
39%
Fluorescence in Situ Hybridization
35%
B Cell
27%
Disease
25%
Burkitt's Lymphoma
24%
Adolescent
23%
Oncology
22%
B-Cell Chronic Lymphocytic Leukemia
22%
Pediatrics
22%
Follicular Lymphoma
22%
Malignant Neoplasm
20%
B-Cell Lymphoma
18%
Chromosome Aberration
18%
Turner Syndrome
17%
Anaplastic Large Cell Lymphoma
15%
Overall Survival
14%
Germinal Center
13%
Event Free Survival
13%
Immunohistochemistry
12%
Tumor Cell
11%
Pathologist
11%
Lymphoma
11%
Metastatic Carcinoma
10%
Lymphoma Cell
10%
Leukemia
10%
Gene Rearrangement
10%
Morphology
10%
Rituximab
10%
Karyotype
10%
Clinical Feature
9%
Large-Cell Lymphoma
9%
Diagnosis
9%
Germinal Center B-Cell Like Diffuse Large B-Cell Lymphoma
9%
Gene Expression
8%
Anaplastic Lymphoma Kinase
8%
Rhabdomyosarcoma
8%
MALT Lymphoma
8%
Cutis Laxa
8%
Classical Hodgkin Lymphoma
8%
Acute Myeloid Leukemia
8%
Epstein Barr Virus
8%
Chromosome 6
8%
Large Cell
8%
Ewing Sarcoma
8%
Multiple Myeloma
8%
Mammary Analog Secretory Carcinoma
8%
Molecular Diagnostics
8%
Lymph Node
8%
Chromosome Analysis
8%
Bone Marrow Transplantation
8%
Differential Diagnosis
8%
Trisomy 12
7%
Clinical Trial
7%
Drug Megadose
7%
Chromosome Translocation
7%
Programmed Cell Death
7%
Surgery
6%
Cancer
6%
Nodular Melanoma
6%
Chemoradiotherapy
6%
Cancer Diagnosis
6%
Facies
6%
Gene Expression Profiling
6%
Cytotechnology
6%
Soft Tissue Sarcoma
6%
Immunophenotyping
5%
In Vitro
5%
Biological Marker
5%
Biopsy
5%
Well Differentiated Liposarcoma
5%
Tumor Invasion
5%
Codon
5%
Risk Stratification
5%
Peripheral T-Cell Lymphoma
5%
Adenocarcinoma
5%
Central Nervous System
5%
Hodgkin's Lymphoma
5%
Child
5%
Clear Cell Renal Cell Carcinoma
5%
Gene Mutation
5%
Imatinib
5%
Immunoblastic Lymphoma
5%
Chromosome Change
5%
Next Generation Sequencing
5%
Minimal Residual Disease
5%
Prevalence
5%
Lymph Node Biopsy
5%
Philadelphia 1 Chromosome
5%
Immunoglobulin Heavy Chain Gene
5%
Gene Fusion
5%
Biochemistry, Genetics and Molecular Biology
Cytogenetics
100%
B Cell
74%
Fluorescence in Situ Hybridization
47%
Genetics
27%
Karyotype
22%
T Cell
21%
Chromosomal Abnormalities
19%
Gene Expression
14%
Gene Expression Profiling
13%
Ewing Sarcoma
12%
Microarrays
12%
Case-Control Study
12%
Trisomy
12%
Oncogene C Myc
11%
Isoform
10%
Chromosome Abnormality
10%
P53
10%
Morphology
9%
Array Comparative Genomic Hybridization
9%
Cell Cycle
9%
Gene Mutation
9%
CD30
8%
Chromosome Band
8%
Mouse
8%
Chromosome 6
8%
Chromosome Marker
8%
Fibroblast
8%
DNA Content
8%
Cyclin D1
8%
Microsatellite Instability
8%
Chromosomal Translocation
8%
BCL6
8%
Monosomy
7%
Signal Transduction
7%
Marker Chromosome
7%
Mosaicism
7%
Polymerase Chain Reaction
7%
P73
6%
Tumor Suppressor Gene
6%
Bcl-2
6%
Cell Proliferation
6%
Precursor
6%
Overall Survival
6%
Cigarette Smoking
6%
Genetic Evaluation
6%
Promoter Region
6%
Event Free Survival
6%
Chromosome 2
5%
Chromosome 7
5%
Fusion Gene
5%
Chromosome 13
5%
X Chromosome
5%
Lymphocyte
5%
Genetic Imbalance
5%
Oncogene
5%
Chromosome 1
5%
Genetic Screening
5%
Gene Locus
5%
Reciprocal Chromosome Translocation
5%
Gene Rearrangement
5%
Chromosome 14
5%
Keyphrases
Cytogenetic Abnormalities
18%
Non-Hodgkin Lymphoma
16%
Epstein-Barr Virus
15%
Follicular Lymphoma
14%
Lymphoma
14%
Burkitt Lymphoma
13%
Peripheral T-cell Lymphoma
12%
C-Myc
11%
Chromosome Abnormalities
11%
B-CLL
10%
Lymphoproliferative Disorders
10%
Tumor
10%
Cytogenetic Findings
9%
Immunophenotypic Profile
9%
Copy number Variation
9%
B-cell Lymphoma 2 (Bcl-2)
8%
Chronic Lymphocytic Leukemia
8%
Val66Met Polymorphism
8%
Children's Oncology Group
8%
Virus Status
8%
Interleukin-8
8%
Leukemia
8%
Clinicopathologic Study
8%
Anaplastic Large Cell Lymphoma
8%
TAp73
8%
Group Reports
8%
Multiple Myeloma
8%
Overexpression
8%
Clinical Significance
7%
Pediatric
7%
B Cells
6%
BCL6
6%
Cytogenetic Analysis
6%
T-cell Lymphoma
6%
Immunophenotyping
6%
Diffuse Large B-cell Lymphoma (DLBCL)
6%
Malignant Lymphoma
5%
VLA-4
5%
Burkitt
5%
Cytogenetic Study
5%
Chromosome 2
5%
Trisomy 12
5%
Neoplasms
5%
Bone Marrow
5%
Fluorescence in Situ Hybridization
5%
MYC Translocation
5%
Molecular Diagnostics
5%
Lymphomagenesis
5%
Severe Combined Immunodeficient Mice
5%
Tumor Cells
5%
Immunoblastic
5%
Cell Proliferation
5%
Rituximab
5%
Triple-hit Lymphoma
5%